A Study to Compare Two Paracetamol Tablets

GlaxoSmithKline (GSK)

Status and phase: Withdrawn; Phase 1

Conditions: Healthy Subjects

Treatments: Drug: Experimental paracetamol formulation; Drug: Marketed paracetamol

Study type: Interventional

Funder types: Industry

Identifiers

NCT01381640

A4040689

Details and patient eligibility

About

This is a single dose pharmacoscintigraphic study investigating the differences in paracetamol absorption between two formulations.

Sex: Male

Ages: 18 to 55 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Healthy male subjects who are in good general health
• Have not exceeded the limits of total radiation exposure (5mSv) allowed in any 12 month period

Trial design

0 participants in 2 patient groups

Marketed paracetamol

Active Comparator group

Description:

Marketed formulation

Treatment:

Drug: Marketed paracetamol

Experimental paracetamol formulation

Experimental group

Description:

Experimental formulation

Treatment:

Drug: Experimental paracetamol formulation